BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 24132760)

  • 1. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A; Rendell JM; Geddes J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium for acute mania.
    McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.
    Cipriani A; Rendell J; Geddes JR
    J Psychopharmacol; 2010 Dec; 24(12):1729-38. PubMed ID: 19828571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate for acute mania.
    Jochim J; Rifkin-Zybutz RP; Geddes J; Cipriani A
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD004052. PubMed ID: 31621892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol alone or in combination for acute mania.
    Cipriani A; Rendell JM; Geddes JR
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004362. PubMed ID: 16856043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine in the maintenance treatment of bipolar disorder.
    Hashimoto Y; Kotake K; Watanabe N; Fujiwara T; Sakamoto S
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013575. PubMed ID: 34523118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines versus placebo for panic disorder in adults.
    Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants versus placebo for panic disorder in adults.
    Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate for acute affective episodes in bipolar disorder in adults.
    Pigott K; Galizia I; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003384. PubMed ID: 27591453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.